Treatment of Acute Ischemic Stroke with Recombinant Tissue Plasminogen Activator: Evaluation with Regional Cerebral Blood Flow Single Photon Emission Computed Tomography
The objectives of the study described in this contribution were to run a pilot study on the efficacy and safety of recombinant tissue plasminogen activator (rt-PA) treatment in patients with intermediate MCA ischemic lesions and to assess the efficacy of perfusion with noninvasive neuroimaging with technetium-99 m hexamethyl propyleneamine oxime (TcHMPAO) regional cerebral blood flow (rCBF) single photon emission computed tomography (SPECT).
KeywordsSingle Photon Emission Compute Tomography Acute Ischemic Stroke Regional Cerebral Blood Flow None None Recombinant Tissue Plasminogen Activator
Unable to display preview. Download preview PDF.